As the global economy recovers in 2021 and the supply of the industrial chain improves, the CAR T-Cell Therapy market will undergo major changes. According to the latest research, the market size of the CAR T-Cell Therapy industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global CAR T-Cell Therapy industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global CAR T-Cell Therapy market during the next few years. The global CAR T-Cell Therapy market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The CAR T-Cell Therapy market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Player list
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
Types list
CD19 - Targeted
BCMA - Targeted
Application list
Lymphoma
Multiple Myeloma
Table of Content
1 CAR T-Cell Therapy Market Introduction and Overview
1.1 CAR T-Cell Therapy Introduction
1.2 Research Purposes
1.3 Report Timeline
1.4 Market Size Analysis by Types
1.5 Market Size Analysis by Applications
1.6 Market Size Analysis by Regions
2 Global Market Growth Trends Analysis
2.1 Global CAR T-Cell Therapy Market Size & Forecast (2017-2028)
2.2 CAR T-Cell Therapy Growth Trends Analysis by Regions
2.2.1 CAR T-Cell Therapy Market Size by Regions: 2017 VS 2021 VS 2027
2.2.2 CAR T-Cell Therapy Historic Market Share by Regions (2017-2022)
2.2.3 CAR T-Cell Therapy Forecasted Market Size by Regions (2023-2028)
3 Global CAR T-Cell Therapy Historical and Forecast Market Analysis by Type
3.1 Global CAR T-Cell Therapy Revenue and Market Share by Type
3.2 Global CAR T-Cell Therapy Market Forecast by Type (2023-2028)
4 Global CAR T-Cell Therapy Historical and Forecast Market Analysis by Applications
4.1 Global CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
4.2 CAR T-Cell Therapy Market Forecast by Application (2023-2028)
5 North America CAR T-Cell Therapy Market analysis
5.1 North America CAR T-Cell Therapy Revenue by Type (2017-2028)
5.2 North America CAR T-Cell Therapy Revenue by Application (2017-2028)
5.3 North America CAR T-Cell Therapy Revenue and Market Share by Countries
5.3.1 North America CAR T-Cell Therapy Revenue by Country (2017-2028)
5.3.2 United States CAR T-Cell Therapy Revenue and Growth (2017-2028)
5.3.3 Canada CAR T-Cell Therapy Revenue and Growth (2017-2028)
5.3.5 Mexico CAR T-Cell Therapy Revenue and Growth (2017-2028)
6 Europe CAR T-Cell Therapy Market analysis
6.1 Europe CAR T-Cell Therapy Revenue by Type (2017-2028)
6.2 Europe CAR T-Cell Therapy Revenue by Application (2017-2028)
6.3 Europe CAR T-Cell Therapy Revenue and Market Share by Countries
6.3.1 Europe CAR T-Cell Therapy Revenue by Country (2017-2028)
6.3.2 Germany CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.3 France CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.4 United Kingdom CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.5 Russia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
6.3.6 Italy CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7 Asia-Pacific CAR T-Cell Therapy Market analysis
7.1 Asia-Pacific CAR T-Cell Therapy Revenue by Type (2017-2028)
7.2 Asia-Pacific CAR T-Cell Therapy Revenue by Application (2017-2028)
7.3 Asia-Pacific CAR T-Cell Therapy Revenue and Market Share by Countries
7.3.1 Asia-Pacific CAR T-Cell Therapy Revenue by Country (2017-2028)
7.3.2 China CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.3 Japan CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.4 South Korea CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.5 India CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.6 Southeast Asia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
7.3.7 Australia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
8 Latin America CAR T-Cell Therapy Market analysis
8.1 Latin America CAR T-Cell Therapy Revenue by Type (2017-2028)
8.2 Latin America CAR T-Cell Therapy Revenue by Application (2017-2028)
8.3 Latin America CAR T-Cell Therapy Revenue and Market Share by Countries
8.3.1 Latin America CAR T-Cell Therapy Revenue by Country (2017-2028)
8.3.2 Brazil CAR T-Cell Therapy Market Size and Forecast (2017-2028)
8.3.3 Argentina CAR T-Cell Therapy Market Size and Forecast (2017-2028)
9 Middle East & Africa CAR T-Cell Therapy Market analysis
9.1 Middle East & Africa CAR T-Cell Therapy Revenue by Type (2017-2028)
9.2 Middle East & Africa CAR T-Cell Therapy Revenue by Application (2017-2028)
9.3 Middle East & Africa CAR T-Cell Therapy Revenue and Market Share by Countries
9.3.1 Middle East & Africa CAR T-Cell Therapy Revenue by Country (2017-2028)
9.3.2 Turkey CAR T-Cell Therapy Market Size and Forecast (2017-2028)
9.3.3 Saudi Arabia CAR T-Cell Therapy Market Size and Forecast (2017-2028)
9.3.4 UAE CAR T-Cell Therapy Market Size and Forecast (2017-2028)
10 CAR T-Cell Therapy Industry Dynamic Analysis
10.1 CAR T-Cell Therapy Market Trends Analysis
10.2 CAR T-Cell Therapy Market Drivers Analysis
10.3 CAR T-Cell Therapy Market Challenges Analysis
10.4 CAR T-Cell Therapy Market Restraints Analysis
10.5 CAR T-Cell Therapy Industry Mergers & Acquisitions
10.6 CAR T-Cell Therapy Industry New Entrants and Expansion Plans
11 Key Players Analysis
11.1 Global CAR T-Cell Therapy Revenue and Market Share Analysis by Key Players
11.2 Global CAR T-Cell Therapy Market Concentration Rate Analysis
11.2.1 Top 3 CAR T-Cell Therapy Key Players Market Share
11.2.2 Top 6 CAR T-Cell Therapy Key Players Market Share
11.3 Novartis
11.3.1 Business Overview
11.3.2 CAR T-Cell Therapy Major Business
11.3.3 Novartis Product and Service Introduction
11.3.4 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.3.5 Recent Developments and Future Plans
11.4 Gilead Sciences
11.4.1 Business Overview
11.4.2 CAR T-Cell Therapy Major Business
11.4.3 Gilead Sciences Product and Service Introduction
11.4.4 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.4.5 Recent Developments and Future Plans
11.5 Bristol-Myers Squibb
11.5.1 Business Overview
11.5.2 CAR T-Cell Therapy Major Business
11.5.3 Bristol-Myers Squibb Product and Service Introduction
11.5.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.5.5 Recent Developments and Future Plans
11.6 J & J
11.6.1 Business Overview
11.6.2 CAR T-Cell Therapy Major Business
11.6.3 J & J Product and Service Introduction
11.6.4 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.6.5 Recent Developments and Future Plans
11.7 JW Therapeutics
11.7.1 Business Overview
11.7.2 CAR T-Cell Therapy Major Business
11.7.3 JW Therapeutics Product and Service Introduction
11.7.4 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.7.5 Recent Developments and Future Plans
11.8 FOSUNKite
11.8.1 Business Overview
11.8.2 CAR T-Cell Therapy Major Business
11.8.3 FOSUNKite Product and Service Introduction
11.8.4 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.8.5 Recent Developments and Future Plans
11.9 CARsgen Therapeutics (Pipeline)
11.9.1 Business Overview
11.9.2 CAR T-Cell Therapy Major Business
11.9.3 CARsgen Therapeutics (Pipeline) Product and Service Introduction
11.9.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.9.5 Recent Developments and Future Plans
11.10 Autolus Therapeutics(Pipeline)
11.10.1 Business Overview
11.10.2 CAR T-Cell Therapy Major Business
11.10.3 Autolus Therapeutics(Pipeline) Product and Service Introduction
11.10.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.10.5 Recent Developments and Future Plans
11.11 Sorrento Therapeutics(Pipeline)
11.11.1 Business Overview
11.11.2 CAR T-Cell Therapy Major Business
11.11.3 Sorrento Therapeutics(Pipeline) Product and Service Introduction
11.11.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.11.5 Recent Developments and Future Plans
11.12 Mustang Bio(Pipeline)
11.12.1 Business Overview
11.12.2 CAR T-Cell Therapy Major Business
11.12.3 Mustang Bio(Pipeline) Product and Service Introduction
11.12.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.12.5 Recent Developments and Future Plans
11.13 Bluebird Bio(Pipeline)
11.13.1 Business Overview
11.13.2 CAR T-Cell Therapy Major Business
11.13.3 Bluebird Bio(Pipeline) Product and Service Introduction
11.13.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.13.5 Recent Developments and Future Plans
11.14 Cellectis(Pipeline)
11.14.1 Business Overview
11.14.2 CAR T-Cell Therapy Major Business
11.14.3 Cellectis(Pipeline) Product and Service Introduction
11.14.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.14.5 Recent Developments and Future Plans
11.15 Allogene Therapeutics(Pipeline)
11.15.1 Business Overview
11.15.2 CAR T-Cell Therapy Major Business
11.15.3 Allogene Therapeutics(Pipeline) Product and Service Introduction
11.15.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.15.5 Recent Developments and Future Plans
11.16 Celyad(Pipeline)
11.16.1 Business Overview
11.16.2 CAR T-Cell Therapy Major Business
11.16.3 Celyad(Pipeline) Product and Service Introduction
11.16.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share
11.16.5 Recent Developments and Future Plans
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.2.3 Legal Disclaimer
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/north-america[2] https://www.marketresearchreports.com/countries/europe[3] https://www.marketresearchreports.com/countries/china[4] https://www.marketresearchreports.com/countries/japan[5] https://www.marketresearchreports.com/countries/global[6] https://www.marketresearchreports.com/healthcare[7] https://www.marketresearchreports.com/pharma-healthcare